Related Experiment Video
Updated: Jun 20, 2026

07:24
Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid
Published on: May 25, 2022
Wanted, dead or alive: new viral vaccines
1Najít Technologies, Inc., Suite 200, Portland, OR 97201, USA. iamanna@najittech.com
Antiviral Research
|September 8, 2009
Summary
Live attenuated vaccines are often considered superior to non-replicating vaccines. This review explores exceptions and historical data to improve future vaccine development, including for HIV.
Area of Science:
- Immunology
- Vaccinology
Background:
- Vaccination is a cornerstone of public health for infectious disease prevention.
- Vaccines are broadly categorized into replicating (live, attenuated) and non-replicating (inactivated, subunit) types.
- A prevailing view suggests live attenuated vaccines offer superior immune responses and protection duration.
Purpose of the Study:
- To critically examine the assumption of live attenuated vaccine superiority.
- To explore historical data and "Experiments of Nature" that challenge this viewpoint.
- To inform the development of next-generation vaccines, including for HIV.
Main Methods:
- Literature review of historical vaccine studies.
- Analysis of case studies comparing replicating and non-replicating vaccine efficacy.
- Examination of immunological response data.
Main Results:
- Identified several exceptions where non-replicating vaccines demonstrate comparable or superior efficacy.
- Highlighted instances where the quality, level, and duration of immunity differ from the general assumption.
- Provided examples from historical data and natural experiments.
Conclusions:
- The superiority of live attenuated vaccines is not absolute and requires nuanced understanding.
- Further research into vaccine mechanisms can guide the creation of improved and novel vaccines.
- A deeper comprehension of vaccine efficacy is crucial for addressing global health challenges like HIV.
Related Concept Videos
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Vaccinations
Overview
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cross-reactivity
Overview
